Fortress Biotech, Inc. (FBIO)
2.93
+0.06
(+2.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.93
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Net Income (Quarterly) : 0.602M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.602M |
| March 31, 2026 | 137.16M |
| December 31, 2025 | -5.397M |
| September 30, 2025 | 8.827M |
| June 30, 2025 | -11.65M |
| March 31, 2025 | -24.69M |
| December 31, 2024 | -26.32M |
| September 30, 2024 | -26.69M |
| June 30, 2024 | -28.82M |
| March 31, 2024 | -39.02M |
| December 31, 2023 | -28.98M |
| September 30, 2023 | -10.72M |
| June 30, 2023 | -59.30M |
| March 31, 2023 | -55.14M |
| December 31, 2022 | -57.44M |
| September 30, 2022 | -53.06M |
| June 30, 2022 | -53.93M |
| March 31, 2022 | -49.48M |
| December 31, 2021 | -68.51M |
| September 30, 2021 | -45.86M |
| June 30, 2021 | -24.39M |
| March 31, 2021 | -26.07M |
| December 31, 2020 | -20.49M |
| September 30, 2020 | -29.96M |
| June 30, 2020 | -28.46M |
| Date | Value |
|---|---|
| March 31, 2020 | -24.07M |
| December 31, 2019 | -32.96M |
| September 30, 2019 | -24.97M |
| June 30, 2019 | -27.48M |
| March 31, 2019 | -16.26M |
| September 30, 2018 | -31.23M |
| June 30, 2018 | -28.80M |
| March 31, 2018 | -36.14M |
| December 31, 2017 | -26.02M |
| September 30, 2017 | -36.31M |
| June 30, 2017 | -22.95M |
| March 31, 2017 | -14.56M |
| December 31, 2016 | -21.30M |
| September 30, 2016 | -16.96M |
| June 30, 2016 | -16.39M |
| March 31, 2016 | -16.64M |
| December 31, 2015 | -15.08M |
| September 30, 2015 | -19.86M |
| June 30, 2015 | -6.418M |
| March 31, 2015 | -12.54M |
| December 31, 2014 | -3.713M |
| September 30, 2014 | -4.592M |
| June 30, 2014 | -4.711M |
| March 31, 2014 | -7.37M |
| December 31, 2013 | -9.798M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | -6.012M |
| Ironwood Pharmaceuticals, Inc. | 51.29M |
| Kura Oncology, Inc. | -68.33M |
| Spero Therapeutics, Inc. | -9.552M |
| Cue Biopharma, Inc. | -153.07M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 18.72M |
| Total Expenses (Quarterly) | 19.19M |
| EPS Diluted (Quarterly) | -0.0779 |
| Enterprise Value | -3.710M |
| Gross Profit Margin (Quarterly) | 61.50% |
| Profit Margin (Quarterly) | 3.22% |
| Earnings Yield | 90.67% |
| Normalized Earnings Yield | 83.57 |